有谁知道吗?Athens Research试剂产品信息 人血浆holo转铁蛋白,有谁知道吗?

蚂蚁淘试剂仪器进口代购，线上商城下单，价格优势，物流透明，采购快人一步！

蚂蚁淘常见平行进口产品有：

Thermofisher旗下Gibco培养系列、ABI细胞计数仪及PCR仪、Invitrogen分子生物学试剂及Qubit3.0、Ambion的RNA相关试剂、Molecular probes试剂、Pierce蛋白相关试剂盒、Nanodrop One/OneC；Parafilm封口膜；Viskase透析袋；Sigma-Aldrich试剂；AccuStandard 标准品；Millipore抗体；Glen Research 核酸合成试剂；Bio-Rad电泳仪及PCR仪；Nanocs的PEG聚合物；  Chromotek羊驼抗体；   Polysciences转染试剂；  Echelon-inc 脂类研究试剂盒；   R&D Systems抗体及Elisa试剂盒； Jackson二抗及封闭血清； Biotium 荧光染料；NEB内切酶及NGS相关产品；  Athens Research & Technology人类蛋白及抗血清；  Illumina二代测试试剂盒； Tocris 小分子试剂； TwistDx恒温扩增试剂盒（RPA）； Enzymatics二代测序酶；Novus抗体及Elisa试剂盒；AG scientific潮霉素B、放线菌酮、G-418；Plantmedia植物培养系列及抗体；Agilent 2100生物分析仪；Biolog耗材；Biomatik的Elisa试剂盒；Covaris基因打断仪；CST抗体；Dharmacon的siRNA产品。

Myeloperoxidase Enzyme Immunoassay Kit

髓过氧化物酶 免疫分析试剂盒

Human MPO EIA KIT FEATURES:

USE - Measure human MPO in a variety of matrices
SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media
SAMPLES / KIT - 40 in duplicate
SENSITIVITY - 0.068 ng/mL
STABILITY - liquid reagents stable at 4°C
QUICK RESULTS - 2.5 HOURS

Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency.

Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.